Standout Papers

Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enter... 2017 2026 2020 2023 466
  1. Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae (2017)
    David van Duin, Judith J. Lok et al. Clinical Infectious Diseases

Immediate Impact

58 standout
Sub-graph 1 of 22

Citing Papers

ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
Carbapenem-resistant Klebsiella pneumoniae capsular types, antibiotic resistance and virulence factors in China: a longitudinal, multi-centre study
2024 Standout
1 intermediate paper

Works of Michelle Earley being referenced

Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
2017 Standout

Author Peers

Author Last Decade Papers Cites
Michelle Earley 24 165 10 419 291 16 510
Irene Gracia-Ahufinger 12 265 4 389 189 29 562
Paraskevi Tselioti 63 181 3 306 159 11 564
Georgios L. Voulgaris 36 240 2 301 282 9 532
Patrick McLeroth 32 185 317 227 11 528
Lambrini Galani 32 205 9 312 194 14 534
Marcello Meledandri 16 177 4 304 152 14 486
Kai‐Tai Chang 4 152 1 389 313 20 536
Patrizia Murino 14 203 341 236 13 549
John S. Esterly 12 129 25 213 131 25 541
Panagiotis Poulikakos 6 152 2 413 195 8 510

All Works

Loading papers...

Rankless by CCL
2026